{"gene":"DCLK2","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":2004,"finding":"DCLK2 (DCK2) has a microtubule (MT) binding activity associated with its doublecortin-like (DC) domain and protein kinase activity mediated by a separate kinase domain, which are functionally independent. Overexpression of DCK2 stabilizes the MT cytoskeleton against cold-induced depolymerization. Autophosphorylation of DCK2 strongly reduces its affinity for MTs, suggesting a phosphorylation-dependent switch for reversible control of MT dynamics. In sympathetic neurons, DCK2 localizes to the cell body and to terminal segments of axons and dendrites.","method":"Domain analysis, in vitro MT binding assays, cold-induced depolymerization assay, autophosphorylation assay, overexpression in neurons with immunolocalization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro assays with mutagenesis/domain analysis and direct localization with functional consequence","pmids":["15611072"],"is_preprint":false},{"year":2006,"finding":"DCLK2 (CLICK-II/DCAMKL2) contains a full N-terminal doublecortin-like domain and a CaMKI/CaMKIV-related kinase domain. Unlike CaMKI/CaMKIV and CaMKII which activate CREB-dependent transcription, DCLK2 is unable to significantly phosphorylate CREB Ser-133 and instead inhibits CRE-dependent gene expression by a dominant mechanism bypassing CREB, mediated through phosphorylated TORC2.","method":"cDNA cloning, CRE-reporter assays, CREB phosphorylation assays, overexpression in neurons","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical assays with reporter readouts and mechanistic pathway placement, moderate evidence from single lab with multiple orthogonal methods","pmids":["16684769"],"is_preprint":false},{"year":2009,"finding":"Dcx;Dclk2-null double knockout mice display spontaneous hippocampal seizures, loss of somatostatin-positive interneurons, dosage-dependent disrupted hippocampal lamination, and cell-autonomous simplification of pyramidal dendritic arborizations leading to reduced inhibitory synaptic tone. Dcx and Dclk2 are coexpressed in developing hippocampus and together are required for proper hippocampal neuronal maturation.","method":"Double-knockout mouse model, seizure monitoring, immunohistochemistry, electrophysiology, c-fos expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via double-knockout with multiple defined cellular phenotypes and functional readouts","pmids":["19342486"],"is_preprint":false},{"year":2014,"finding":"Zebrafish DCLK2 is proteolytically cleaved into two functional fragments: an N-terminal fragment with microtubule-binding activity and a C-terminal kinase fragment with Ser/Thr kinase activity. Under hyperosmotic stress (NaCl or mannitol), the kinase fragment translocates from cytoplasm to nucleus. By two-hybrid screening, JDP2 (Jun dimerization protein 2) was identified as a binding partner of the DCLK2 kinase domain, and DCLK2 kinase efficiently phosphorylates JDP2 in the presence of histone.","method":"Proteolytic cleavage analysis, subcellular fractionation/live imaging under osmotic stress, yeast two-hybrid screening, in vitro kinase assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional consequence and substrate identification, but single lab with zebrafish ortholog","pmids":["24582561"],"is_preprint":false},{"year":2024,"finding":"DCLK2 binds to and directly phosphorylates TBK1 on Ser172 to activate TBK1 signaling in clear cell renal cell carcinoma (ccRCC). A short isoform, DCLK2203, predominates in ccRCC and promotes cell growth and tumorigenesis via TBK1 phosphorylation and activation. Depletion of DCLK2 inhibits anchorage-independent colony growth and kidney tumorigenesis in orthotopic xenograft models.","method":"Kinome-wide siRNA screen, Co-immunoprecipitation, in vitro kinase assay, site-specific mutagenesis (Ser172), orthotopic xenograft models, knockdown/overexpression","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — kinome-wide screen identified substrate, confirmed by direct kinase assay, Co-IP, mutagenesis, and in vivo models in single rigorous study","pmids":["38211588"],"is_preprint":false},{"year":2025,"finding":"BBOX1 suppresses ccRCC by disrupting the interaction between DCLK2 and TBK1, thereby preventing DCLK2-mediated TBK1 activation. This defines DCLK2 as an upstream activator of TBK1-mTORC1 signaling in ccRCC, with BBOX1 acting as a negative regulator by blocking the DCLK2-TBK1 interaction.","method":"Co-immunoprecipitation, BBOX1 restoration xenograft experiments, transcriptomic analysis, knockdown/overexpression","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — Co-IP demonstrating protein interaction disruption with in vivo xenograft validation, corroborates findings from PMID:38211588","pmids":["39934163"],"is_preprint":false},{"year":2024,"finding":"Cpeb4 upregulates Dclk2 expression by increasing Dclk2 mRNA stability. Dclk2 phosphorylates the transcription factor Ehf, causing its translocation from nucleus to cytoplasm (decreased nuclear Ehf), which releases Ehf-mediated repression of Caspase1 and Caspase3 promoters, thereby promoting neuronal pyroptosis in chronic cerebral ischemia.","method":"RNA stability assays, knockdown experiments in OGD-treated HT22 cells and CCI mouse model, in vitro kinase assay for Ehf phosphorylation, subcellular fractionation, promoter activity assays","journal":"Journal of cerebral blood flow and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — direct kinase-substrate relationship established with functional pathway placement in ischemia model, single lab study","pmids":["38513137"],"is_preprint":false},{"year":2022,"finding":"DCLK2 promotes breast cancer cell invasion, migration, and lung metastasis, and drives epithelial-mesenchymal transition (EMT). TCF4/β-catenin inhibitor LF3 downregulates DCLK2 expression and inhibits breast cancer migration and invasion, placing DCLK2 downstream of TCF4/β-catenin signaling. Silencing DCLK2 does not affect proliferation but suppresses invasiveness.","method":"Lentiviral overexpression and knockdown, Transwell invasion/migration assays, tail vein metastasis model, western blot for EMT markers, bioinformatics correlation analysis","journal":"Clinical & translational oncology","confidence":"Medium","confidence_rationale":"Tier 2-3 — defined cellular and in vivo phenotype with pathway placement via inhibitor, single lab study","pmids":["36477947"],"is_preprint":false},{"year":2023,"finding":"DCLK2 was identified as a BAF complex-interacting kinase whose inhibition selectively attenuates BAF complex phosphorylation following synaptic activity (membrane depolarization) in neurons, placing DCLK2 as a kinase upstream of activity-dependent BAF phosphorylation.","method":"Biochemical pulldown/interaction mapping, chemical kinase inhibition, phosphoproteomic analysis of BAF complexes following membrane depolarization","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 — preprint, single lab, interaction and inhibition data without full mechanistic reconstitution","pmids":["37873481"],"is_preprint":true},{"year":2008,"finding":"Dclk2 is expressed both in proliferating cells and postmitotic neurons during development, with strong expression in the ventral telencephalon. Alternative transcripts of Dclk2 were characterized. No major changes in Dclk2 expression at RNA or protein levels were found in Dcx knockout mice, indicating Dclk2 does not compensatorily upregulate in the absence of Dcx.","method":"Northern blot, in situ hybridization, immunostaining in wild-type and Dcx-knockout mice","journal":"Developmental neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — direct expression localization with functional epistasis interpretation in knockout model","pmids":["18075264"],"is_preprint":false}],"current_model":"DCLK2 is a dual-domain protein kinase containing an N-terminal doublecortin-like microtubule-binding domain and a C-terminal Ser/Thr kinase domain that are functionally independent; it stabilizes microtubule dynamics (regulated by autophosphorylation), inhibits CRE-dependent transcription via TORC2 (not CREB), phosphorylates TBK1 Ser172 to activate TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma (counteracted by BBOX1), phosphorylates the transcription factor Ehf to promote its nuclear export and drive neuronal pyroptosis, phosphorylates JDP2 in the nucleus under osmotic stress, interacts with the BAF chromatin remodeling complex to mediate activity-dependent phosphorylation in neurons, and is required together with DCX for proper hippocampal pyramidal neuron maturation and inhibitory synaptic tone."},"narrative":{"teleology":[{"year":2004,"claim":"Establishing that DCLK2 possesses two functionally independent domains — a microtubule-binding doublecortin domain and a kinase domain — resolved how a single protein can separately regulate cytoskeletal stability and phosphorylation-based signaling, with autophosphorylation serving as a reversible switch between these activities.","evidence":"Domain-deletion constructs, in vitro MT binding and cold-depolymerization assays, autophosphorylation assays, and neuronal immunolocalization","pmids":["15611072"],"confidence":"High","gaps":["Identity of kinases or phosphatases that regulate DCLK2 autophosphorylation in vivo unknown","Structural basis for how autophosphorylation reduces MT affinity not resolved","Whether both domains function simultaneously in physiological contexts not tested"]},{"year":2006,"claim":"Despite its CaMK-related kinase domain, DCLK2 does not activate CREB but instead inhibits CRE-dependent transcription through TORC2 phosphorylation, establishing a previously unrecognized divergent transcriptional output for this kinase family member.","evidence":"CRE-reporter assays, CREB Ser133 phosphorylation assays, and TORC2-dependent mechanism dissection in neurons","pmids":["16684769"],"confidence":"High","gaps":["Direct phosphorylation sites on TORC2 by DCLK2 not mapped","Physiological contexts requiring DCLK2-mediated CRE inhibition not identified","No in vivo confirmation of TORC2 as the relevant mediator"]},{"year":2008,"claim":"Characterization of Dclk2 developmental expression showed it is present in both progenitors and postmitotic neurons, and is not compensatorily upregulated in Dcx knockouts, setting the stage for understanding their genetic redundancy.","evidence":"Northern blot, in situ hybridization, and immunostaining in wild-type and Dcx-knockout mouse brain","pmids":["18075264"],"confidence":"Medium","gaps":["Post-translational compensation between DCX and DCLK2 not assessed","Functional significance of alternative Dclk2 transcripts not determined"]},{"year":2009,"claim":"Dcx;Dclk2 double-knockout mice revealed that the two genes act redundantly for hippocampal lamination, pyramidal neuron dendritic maturation, and maintenance of inhibitory synaptic tone, explaining why single Dcx knockouts show mild phenotypes.","evidence":"Double-knockout mouse with seizure monitoring, immunohistochemistry, electrophysiology, and c-fos analysis","pmids":["19342486"],"confidence":"High","gaps":["Whether DCLK2's kinase activity or its MT-binding domain mediates the neurodevelopmental phenotype is unknown","Contribution of DCLK2 independent of DCX in single-knockout has not been defined with cell-type specificity"]},{"year":2014,"claim":"Discovery that DCLK2 undergoes proteolytic cleavage releasing a kinase fragment that translocates to the nucleus under osmotic stress and phosphorylates JDP2 revealed a stimulus-responsive nuclear signaling function distinct from its cytoplasmic cytoskeletal role.","evidence":"Proteolytic cleavage analysis, subcellular fractionation and live imaging under hyperosmotic stress, yeast two-hybrid screen, in vitro kinase assay in zebrafish","pmids":["24582561"],"confidence":"Medium","gaps":["Protease responsible for DCLK2 cleavage not identified","Functional consequence of JDP2 phosphorylation on downstream gene expression not established","Findings from zebrafish ortholog await confirmation in mammalian systems"]},{"year":2022,"claim":"Placing DCLK2 downstream of TCF4/β-catenin signaling and showing it drives EMT and metastasis in breast cancer extended its oncogenic functions beyond kinase-substrate relationships to transcriptional regulation of invasion programs.","evidence":"Lentiviral overexpression/knockdown, Transwell assays, tail-vein lung metastasis model, TCF4/β-catenin inhibitor LF3","pmids":["36477947"],"confidence":"Medium","gaps":["Direct DCLK2 substrates mediating EMT not identified","Mechanism by which DCLK2 promotes invasion without affecting proliferation unclear","Single study without independent replication"]},{"year":2024,"claim":"Identification of TBK1 Ser172 as a direct DCLK2 substrate in ccRCC established the first well-defined oncogenic kinase-substrate axis for DCLK2, linking it to mTORC1 activation and tumorigenesis, subsequently validated by the discovery that BBOX1 suppresses this pathway by disrupting the DCLK2-TBK1 interaction.","evidence":"Kinome-wide siRNA screen, Co-IP, in vitro kinase assay, Ser172 mutagenesis, orthotopic xenografts (PMID:38211588); BBOX1 restoration, Co-IP disruption, xenograft validation (PMID:39934163)","pmids":["38211588","39934163"],"confidence":"High","gaps":["Whether DCLK2-TBK1 signaling operates in cancers beyond ccRCC not tested","Structural basis for BBOX1-mediated disruption of the DCLK2-TBK1 interaction unknown","Contribution of the short DCLK2203 isoform versus full-length to normal kidney physiology not addressed"]},{"year":2024,"claim":"Demonstrating that DCLK2 phosphorylates Ehf to promote its nuclear export and derepress Caspase1/3 promoters linked DCLK2 kinase activity to pyroptotic cell death in chronic cerebral ischemia, revealing a non-developmental, pathological neuronal function.","evidence":"In vitro kinase assay for Ehf, subcellular fractionation, promoter assays, OGD-treated HT22 cells and CCI mouse model","pmids":["38513137"],"confidence":"Medium","gaps":["Specific Ehf phosphorylation sites targeted by DCLK2 not mapped","Whether this pyroptosis pathway is active outside ischemia models not explored","Single-lab finding awaiting independent validation"]},{"year":null,"claim":"Key unresolved questions include the structural basis for DCLK2's dual-domain architecture, whether its kinase and MT-binding functions are coordinately deployed in neurons, the identity of the protease cleaving DCLK2, and whether its diverse substrate repertoire (TBK1, Ehf, JDP2, TORC2, BAF) reflects context-specific isoform usage or localization-dependent substrate access.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of DCLK2 available","Isoform-specific functions largely uncharacterized","Integration of MT-binding and kinase functions in a single physiological context not demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,3,4,6]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4,5]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,9]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,5,7]}],"complexes":[],"partners":["TBK1","BBOX1","DCX","JDP2","EHF","TORC2"],"other_free_text":[]},"mechanistic_narrative":"DCLK2 is a dual-domain serine/threonine kinase that couples microtubule regulation with nuclear signaling to control neuronal development, transcriptional programs, and oncogenic pathways. Its N-terminal doublecortin-like domain binds and stabilizes microtubules independently of its C-terminal CaMKI/IV-related kinase domain, and autophosphorylation acts as a switch that reduces microtubule affinity to enable reversible cytoskeletal control [PMID:15611072]. DCLK2 functions redundantly with DCX in hippocampal lamination and pyramidal neuron maturation, as Dcx;Dclk2 double-knockout mice exhibit seizures, interneuron loss, and reduced inhibitory synaptic tone [PMID:19342486]. In cancer, DCLK2 directly phosphorylates TBK1 at Ser172 to activate TBK1-mTORC1 signaling and drive tumorigenesis in clear cell renal cell carcinoma, an interaction counteracted by BBOX1 [PMID:38211588, PMID:39934163], and it phosphorylates the transcription factor Ehf to promote its nuclear export and trigger neuronal pyroptosis during chronic cerebral ischemia [PMID:38513137]."},"prefetch_data":{"uniprot":{"accession":"Q8N568","full_name":"Serine/threonine-protein kinase DCLK2","aliases":["CaMK-like CREB regulatory kinase 2","CL2","CLICK-II","CLICK2","Doublecortin domain-containing protein 3B","Doublecortin-like and CAM kinase-like 2","Doublecortin-like kinase 2"],"length_aa":766,"mass_kda":83.6,"function":"Protein kinase with a significantly reduced C(a2+)/CAM affinity and dependence compared to other members of the CaMK family. May play a role in the down-regulation of CRE-dependent gene activation probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the resulting retention of TORC2 in the cytoplasm (By similarity)","subcellular_location":"Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/Q8N568/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DCLK2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DCLK2","total_profiled":1310},"omim":[{"mim_id":"614994","title":"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IG; CAMK1G","url":"https://www.omim.org/entry/614994"},{"mim_id":"613167","title":"DOUBLECORTIN-LIKE KINASE 3; DCLK3","url":"https://www.omim.org/entry/613167"},{"mim_id":"613166","title":"DOUBLECORTIN-LIKE KINASE 2; DCLK2","url":"https://www.omim.org/entry/613166"},{"mim_id":"300121","title":"DOUBLECORTIN; DCX","url":"https://www.omim.org/entry/300121"},{"mim_id":"300067","title":"LISSENCEPHALY, X-LINKED, 1; LISX1","url":"https://www.omim.org/entry/300067"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":45.8},{"tissue":"retina","ntpm":17.1}],"url":"https://www.proteinatlas.org/search/DCLK2"},"hgnc":{"alias_symbol":["MGC45428","DCDC3","DCDC3B","DCK2"],"prev_symbol":["DCAMKL2"]},"alphafold":{"accession":"Q8N568","domains":[{"cath_id":"3.10.20.230","chopping":"73-148","consensus_level":"high","plddt":85.8478,"start":73,"end":148},{"cath_id":"3.10.20.230","chopping":"198-284","consensus_level":"high","plddt":75.2311,"start":198,"end":284},{"cath_id":"3.30.200.20","chopping":"393-471","consensus_level":"medium","plddt":91.4608,"start":393,"end":471},{"cath_id":"1.10.510.10","chopping":"476-701","consensus_level":"high","plddt":88.5465,"start":476,"end":701}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N568","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N568-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N568-F1-predicted_aligned_error_v6.png","plddt_mean":69.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DCLK2","jax_strain_url":"https://www.jax.org/strain/search?query=DCLK2"},"sequence":{"accession":"Q8N568","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N568.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N568/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N568"}},"corpus_meta":[{"pmid":"21832240","id":"PMC_21832240","title":"Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD.","date":"2011","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21832240","citation_count":283,"is_preprint":false},{"pmid":"29572931","id":"PMC_29572931","title":"Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.","date":"2018","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29572931","citation_count":113,"is_preprint":false},{"pmid":"7282953","id":"PMC_7282953","title":"Cardiac output during cardiopulmonary resuscitation at various compression rates and durations.","date":"1981","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7282953","citation_count":99,"is_preprint":false},{"pmid":"8810266","id":"PMC_8810266","title":"Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8810266","citation_count":71,"is_preprint":false},{"pmid":"31583809","id":"PMC_31583809","title":"Genetics of resilience: Implications from genome-wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression.","date":"2019","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31583809","citation_count":69,"is_preprint":false},{"pmid":"19342486","id":"PMC_19342486","title":"Mice lacking doublecortin and doublecortin-like kinase 2 display altered hippocampal neuronal maturation and spontaneous seizures.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19342486","citation_count":63,"is_preprint":false},{"pmid":"23726375","id":"PMC_23726375","title":"Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link?","date":"2013","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/23726375","citation_count":58,"is_preprint":false},{"pmid":"31081985","id":"PMC_31081985","title":"Genome-wide analyses of psychological resilience in U.S. Army soldiers.","date":"2019","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31081985","citation_count":44,"is_preprint":false},{"pmid":"24239623","id":"PMC_24239623","title":"Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.","date":"2013","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24239623","citation_count":40,"is_preprint":false},{"pmid":"16684769","id":"PMC_16684769","title":"Molecular identification and characterization of a family of kinases with homology to Ca2+/calmodulin-dependent protein kinases I/IV.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16684769","citation_count":32,"is_preprint":false},{"pmid":"16223721","id":"PMC_16223721","title":"dMi-2 chromatin binding and remodeling activities are regulated by dCK2 phosphorylation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16223721","citation_count":30,"is_preprint":false},{"pmid":"15611072","id":"PMC_15611072","title":"Doublecortin kinase-2, a novel doublecortin-related protein kinase associated with terminal segments of axons and dendrites.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15611072","citation_count":29,"is_preprint":false},{"pmid":"29095916","id":"PMC_29095916","title":"Transcriptomic difference in bovine blastocysts following vitrification and slow freezing at morula stage.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29095916","citation_count":28,"is_preprint":false},{"pmid":"18075264","id":"PMC_18075264","title":"Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice.","date":"2008","source":"Developmental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18075264","citation_count":18,"is_preprint":false},{"pmid":"31919093","id":"PMC_31919093","title":"Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukemia.","date":"2021","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/31919093","citation_count":17,"is_preprint":false},{"pmid":"24582561","id":"PMC_24582561","title":"Nuclear translocation of doublecortin-like protein kinase and phosphorylation of a transcription factor JDP2.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24582561","citation_count":11,"is_preprint":false},{"pmid":"38211588","id":"PMC_38211588","title":"Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma.","date":"2024","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/38211588","citation_count":10,"is_preprint":false},{"pmid":"31578829","id":"PMC_31578829","title":"Exome sequencing study of partial agenesis of the corpus callosum in men with developmental delay, epilepsy, and microcephaly.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31578829","citation_count":10,"is_preprint":false},{"pmid":"32109663","id":"PMC_32109663","title":"Gene discovery for high-density lipoprotein cholesterol level change over time in prospective family studies.","date":"2020","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/32109663","citation_count":9,"is_preprint":false},{"pmid":"25784603","id":"PMC_25784603","title":"Hippocampal transcriptional and neurogenic changes evoked by combination yohimbine and imipramine treatment.","date":"2015","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25784603","citation_count":6,"is_preprint":false},{"pmid":"36477947","id":"PMC_36477947","title":"Doublecortin-like kinase 2 promotes breast cancer cell invasion and metastasis.","date":"2022","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/36477947","citation_count":5,"is_preprint":false},{"pmid":"39934163","id":"PMC_39934163","title":"BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39934163","citation_count":5,"is_preprint":false},{"pmid":"38513137","id":"PMC_38513137","title":"Cpeb4-mediated Dclk2 promotes neuronal pyroptosis induced by chronic cerebral ischemia through phosphorylation of Ehf.","date":"2024","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38513137","citation_count":4,"is_preprint":false},{"pmid":"37873481","id":"PMC_37873481","title":"Synaptic Activity Causes Minute-scale Changes in BAF Complex Composition and Function.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37873481","citation_count":4,"is_preprint":false},{"pmid":"39728450","id":"PMC_39728450","title":"Transcriptomic Profiling Reveals Altered Expression of Genes Involved in Metabolic and Immune Processes in NDV-Infected Chicken Embryos.","date":"2024","source":"Metabolites","url":"https://pubmed.ncbi.nlm.nih.gov/39728450","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14387,"output_tokens":2838,"usd":0.042866},"stage2":{"model":"claude-opus-4-6","input_tokens":6154,"output_tokens":2722,"usd":0.14823},"total_usd":0.191096,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"DCLK2 (DCK2) has a microtubule (MT) binding activity associated with its doublecortin-like (DC) domain and protein kinase activity mediated by a separate kinase domain, which are functionally independent. Overexpression of DCK2 stabilizes the MT cytoskeleton against cold-induced depolymerization. Autophosphorylation of DCK2 strongly reduces its affinity for MTs, suggesting a phosphorylation-dependent switch for reversible control of MT dynamics. In sympathetic neurons, DCK2 localizes to the cell body and to terminal segments of axons and dendrites.\",\n      \"method\": \"Domain analysis, in vitro MT binding assays, cold-induced depolymerization assay, autophosphorylation assay, overexpression in neurons with immunolocalization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro assays with mutagenesis/domain analysis and direct localization with functional consequence\",\n      \"pmids\": [\"15611072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DCLK2 (CLICK-II/DCAMKL2) contains a full N-terminal doublecortin-like domain and a CaMKI/CaMKIV-related kinase domain. Unlike CaMKI/CaMKIV and CaMKII which activate CREB-dependent transcription, DCLK2 is unable to significantly phosphorylate CREB Ser-133 and instead inhibits CRE-dependent gene expression by a dominant mechanism bypassing CREB, mediated through phosphorylated TORC2.\",\n      \"method\": \"cDNA cloning, CRE-reporter assays, CREB phosphorylation assays, overexpression in neurons\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical assays with reporter readouts and mechanistic pathway placement, moderate evidence from single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16684769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dcx;Dclk2-null double knockout mice display spontaneous hippocampal seizures, loss of somatostatin-positive interneurons, dosage-dependent disrupted hippocampal lamination, and cell-autonomous simplification of pyramidal dendritic arborizations leading to reduced inhibitory synaptic tone. Dcx and Dclk2 are coexpressed in developing hippocampus and together are required for proper hippocampal neuronal maturation.\",\n      \"method\": \"Double-knockout mouse model, seizure monitoring, immunohistochemistry, electrophysiology, c-fos expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via double-knockout with multiple defined cellular phenotypes and functional readouts\",\n      \"pmids\": [\"19342486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Zebrafish DCLK2 is proteolytically cleaved into two functional fragments: an N-terminal fragment with microtubule-binding activity and a C-terminal kinase fragment with Ser/Thr kinase activity. Under hyperosmotic stress (NaCl or mannitol), the kinase fragment translocates from cytoplasm to nucleus. By two-hybrid screening, JDP2 (Jun dimerization protein 2) was identified as a binding partner of the DCLK2 kinase domain, and DCLK2 kinase efficiently phosphorylates JDP2 in the presence of histone.\",\n      \"method\": \"Proteolytic cleavage analysis, subcellular fractionation/live imaging under osmotic stress, yeast two-hybrid screening, in vitro kinase assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence and substrate identification, but single lab with zebrafish ortholog\",\n      \"pmids\": [\"24582561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DCLK2 binds to and directly phosphorylates TBK1 on Ser172 to activate TBK1 signaling in clear cell renal cell carcinoma (ccRCC). A short isoform, DCLK2203, predominates in ccRCC and promotes cell growth and tumorigenesis via TBK1 phosphorylation and activation. Depletion of DCLK2 inhibits anchorage-independent colony growth and kidney tumorigenesis in orthotopic xenograft models.\",\n      \"method\": \"Kinome-wide siRNA screen, Co-immunoprecipitation, in vitro kinase assay, site-specific mutagenesis (Ser172), orthotopic xenograft models, knockdown/overexpression\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — kinome-wide screen identified substrate, confirmed by direct kinase assay, Co-IP, mutagenesis, and in vivo models in single rigorous study\",\n      \"pmids\": [\"38211588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BBOX1 suppresses ccRCC by disrupting the interaction between DCLK2 and TBK1, thereby preventing DCLK2-mediated TBK1 activation. This defines DCLK2 as an upstream activator of TBK1-mTORC1 signaling in ccRCC, with BBOX1 acting as a negative regulator by blocking the DCLK2-TBK1 interaction.\",\n      \"method\": \"Co-immunoprecipitation, BBOX1 restoration xenograft experiments, transcriptomic analysis, knockdown/overexpression\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP demonstrating protein interaction disruption with in vivo xenograft validation, corroborates findings from PMID:38211588\",\n      \"pmids\": [\"39934163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cpeb4 upregulates Dclk2 expression by increasing Dclk2 mRNA stability. Dclk2 phosphorylates the transcription factor Ehf, causing its translocation from nucleus to cytoplasm (decreased nuclear Ehf), which releases Ehf-mediated repression of Caspase1 and Caspase3 promoters, thereby promoting neuronal pyroptosis in chronic cerebral ischemia.\",\n      \"method\": \"RNA stability assays, knockdown experiments in OGD-treated HT22 cells and CCI mouse model, in vitro kinase assay for Ehf phosphorylation, subcellular fractionation, promoter activity assays\",\n      \"journal\": \"Journal of cerebral blood flow and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct kinase-substrate relationship established with functional pathway placement in ischemia model, single lab study\",\n      \"pmids\": [\"38513137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DCLK2 promotes breast cancer cell invasion, migration, and lung metastasis, and drives epithelial-mesenchymal transition (EMT). TCF4/β-catenin inhibitor LF3 downregulates DCLK2 expression and inhibits breast cancer migration and invasion, placing DCLK2 downstream of TCF4/β-catenin signaling. Silencing DCLK2 does not affect proliferation but suppresses invasiveness.\",\n      \"method\": \"Lentiviral overexpression and knockdown, Transwell invasion/migration assays, tail vein metastasis model, western blot for EMT markers, bioinformatics correlation analysis\",\n      \"journal\": \"Clinical & translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — defined cellular and in vivo phenotype with pathway placement via inhibitor, single lab study\",\n      \"pmids\": [\"36477947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DCLK2 was identified as a BAF complex-interacting kinase whose inhibition selectively attenuates BAF complex phosphorylation following synaptic activity (membrane depolarization) in neurons, placing DCLK2 as a kinase upstream of activity-dependent BAF phosphorylation.\",\n      \"method\": \"Biochemical pulldown/interaction mapping, chemical kinase inhibition, phosphoproteomic analysis of BAF complexes following membrane depolarization\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — preprint, single lab, interaction and inhibition data without full mechanistic reconstitution\",\n      \"pmids\": [\"37873481\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dclk2 is expressed both in proliferating cells and postmitotic neurons during development, with strong expression in the ventral telencephalon. Alternative transcripts of Dclk2 were characterized. No major changes in Dclk2 expression at RNA or protein levels were found in Dcx knockout mice, indicating Dclk2 does not compensatorily upregulate in the absence of Dcx.\",\n      \"method\": \"Northern blot, in situ hybridization, immunostaining in wild-type and Dcx-knockout mice\",\n      \"journal\": \"Developmental neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct expression localization with functional epistasis interpretation in knockout model\",\n      \"pmids\": [\"18075264\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DCLK2 is a dual-domain protein kinase containing an N-terminal doublecortin-like microtubule-binding domain and a C-terminal Ser/Thr kinase domain that are functionally independent; it stabilizes microtubule dynamics (regulated by autophosphorylation), inhibits CRE-dependent transcription via TORC2 (not CREB), phosphorylates TBK1 Ser172 to activate TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma (counteracted by BBOX1), phosphorylates the transcription factor Ehf to promote its nuclear export and drive neuronal pyroptosis, phosphorylates JDP2 in the nucleus under osmotic stress, interacts with the BAF chromatin remodeling complex to mediate activity-dependent phosphorylation in neurons, and is required together with DCX for proper hippocampal pyramidal neuron maturation and inhibitory synaptic tone.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DCLK2 is a dual-domain serine/threonine kinase that couples microtubule regulation with nuclear signaling to control neuronal development, transcriptional programs, and oncogenic pathways. Its N-terminal doublecortin-like domain binds and stabilizes microtubules independently of its C-terminal CaMKI/IV-related kinase domain, and autophosphorylation acts as a switch that reduces microtubule affinity to enable reversible cytoskeletal control [PMID:15611072]. DCLK2 functions redundantly with DCX in hippocampal lamination and pyramidal neuron maturation, as Dcx;Dclk2 double-knockout mice exhibit seizures, interneuron loss, and reduced inhibitory synaptic tone [PMID:19342486]. In cancer, DCLK2 directly phosphorylates TBK1 at Ser172 to activate TBK1-mTORC1 signaling and drive tumorigenesis in clear cell renal cell carcinoma, an interaction counteracted by BBOX1 [PMID:38211588, PMID:39934163], and it phosphorylates the transcription factor Ehf to promote its nuclear export and trigger neuronal pyroptosis during chronic cerebral ischemia [PMID:38513137].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that DCLK2 possesses two functionally independent domains — a microtubule-binding doublecortin domain and a kinase domain — resolved how a single protein can separately regulate cytoskeletal stability and phosphorylation-based signaling, with autophosphorylation serving as a reversible switch between these activities.\",\n      \"evidence\": \"Domain-deletion constructs, in vitro MT binding and cold-depolymerization assays, autophosphorylation assays, and neuronal immunolocalization\",\n      \"pmids\": [\"15611072\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of kinases or phosphatases that regulate DCLK2 autophosphorylation in vivo unknown\",\n        \"Structural basis for how autophosphorylation reduces MT affinity not resolved\",\n        \"Whether both domains function simultaneously in physiological contexts not tested\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Despite its CaMK-related kinase domain, DCLK2 does not activate CREB but instead inhibits CRE-dependent transcription through TORC2 phosphorylation, establishing a previously unrecognized divergent transcriptional output for this kinase family member.\",\n      \"evidence\": \"CRE-reporter assays, CREB Ser133 phosphorylation assays, and TORC2-dependent mechanism dissection in neurons\",\n      \"pmids\": [\"16684769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct phosphorylation sites on TORC2 by DCLK2 not mapped\",\n        \"Physiological contexts requiring DCLK2-mediated CRE inhibition not identified\",\n        \"No in vivo confirmation of TORC2 as the relevant mediator\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterization of Dclk2 developmental expression showed it is present in both progenitors and postmitotic neurons, and is not compensatorily upregulated in Dcx knockouts, setting the stage for understanding their genetic redundancy.\",\n      \"evidence\": \"Northern blot, in situ hybridization, and immunostaining in wild-type and Dcx-knockout mouse brain\",\n      \"pmids\": [\"18075264\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Post-translational compensation between DCX and DCLK2 not assessed\",\n        \"Functional significance of alternative Dclk2 transcripts not determined\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Dcx;Dclk2 double-knockout mice revealed that the two genes act redundantly for hippocampal lamination, pyramidal neuron dendritic maturation, and maintenance of inhibitory synaptic tone, explaining why single Dcx knockouts show mild phenotypes.\",\n      \"evidence\": \"Double-knockout mouse with seizure monitoring, immunohistochemistry, electrophysiology, and c-fos analysis\",\n      \"pmids\": [\"19342486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DCLK2's kinase activity or its MT-binding domain mediates the neurodevelopmental phenotype is unknown\",\n        \"Contribution of DCLK2 independent of DCX in single-knockout has not been defined with cell-type specificity\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that DCLK2 undergoes proteolytic cleavage releasing a kinase fragment that translocates to the nucleus under osmotic stress and phosphorylates JDP2 revealed a stimulus-responsive nuclear signaling function distinct from its cytoplasmic cytoskeletal role.\",\n      \"evidence\": \"Proteolytic cleavage analysis, subcellular fractionation and live imaging under hyperosmotic stress, yeast two-hybrid screen, in vitro kinase assay in zebrafish\",\n      \"pmids\": [\"24582561\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Protease responsible for DCLK2 cleavage not identified\",\n        \"Functional consequence of JDP2 phosphorylation on downstream gene expression not established\",\n        \"Findings from zebrafish ortholog await confirmation in mammalian systems\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placing DCLK2 downstream of TCF4/β-catenin signaling and showing it drives EMT and metastasis in breast cancer extended its oncogenic functions beyond kinase-substrate relationships to transcriptional regulation of invasion programs.\",\n      \"evidence\": \"Lentiviral overexpression/knockdown, Transwell assays, tail-vein lung metastasis model, TCF4/β-catenin inhibitor LF3\",\n      \"pmids\": [\"36477947\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct DCLK2 substrates mediating EMT not identified\",\n        \"Mechanism by which DCLK2 promotes invasion without affecting proliferation unclear\",\n        \"Single study without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of TBK1 Ser172 as a direct DCLK2 substrate in ccRCC established the first well-defined oncogenic kinase-substrate axis for DCLK2, linking it to mTORC1 activation and tumorigenesis, subsequently validated by the discovery that BBOX1 suppresses this pathway by disrupting the DCLK2-TBK1 interaction.\",\n      \"evidence\": \"Kinome-wide siRNA screen, Co-IP, in vitro kinase assay, Ser172 mutagenesis, orthotopic xenografts (PMID:38211588); BBOX1 restoration, Co-IP disruption, xenograft validation (PMID:39934163)\",\n      \"pmids\": [\"38211588\", \"39934163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DCLK2-TBK1 signaling operates in cancers beyond ccRCC not tested\",\n        \"Structural basis for BBOX1-mediated disruption of the DCLK2-TBK1 interaction unknown\",\n        \"Contribution of the short DCLK2203 isoform versus full-length to normal kidney physiology not addressed\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that DCLK2 phosphorylates Ehf to promote its nuclear export and derepress Caspase1/3 promoters linked DCLK2 kinase activity to pyroptotic cell death in chronic cerebral ischemia, revealing a non-developmental, pathological neuronal function.\",\n      \"evidence\": \"In vitro kinase assay for Ehf, subcellular fractionation, promoter assays, OGD-treated HT22 cells and CCI mouse model\",\n      \"pmids\": [\"38513137\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific Ehf phosphorylation sites targeted by DCLK2 not mapped\",\n        \"Whether this pyroptosis pathway is active outside ischemia models not explored\",\n        \"Single-lab finding awaiting independent validation\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for DCLK2's dual-domain architecture, whether its kinase and MT-binding functions are coordinately deployed in neurons, the identity of the protease cleaving DCLK2, and whether its diverse substrate repertoire (TBK1, Ehf, JDP2, TORC2, BAF) reflects context-specific isoform usage or localization-dependent substrate access.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No crystal or cryo-EM structure of DCLK2 available\",\n        \"Isoform-specific functions largely uncharacterized\",\n        \"Integration of MT-binding and kinase functions in a single physiological context not demonstrated\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 3, 4, 6]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 5]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 9]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 5, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TBK1\",\n      \"BBOX1\",\n      \"DCX\",\n      \"JDP2\",\n      \"EHF\",\n      \"TORC2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}